Download PDF
Thromb Haemost 1999; 81(05): 852
DOI: 10.1055/s-0037-1614585
Letters to the Editor
Schattauer GmbH

Is a Change of Factor VIII Product a Risk Factor for the Development of a Factor VIII Inhibitor?

Thynn Thynn Yee
1   From the Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Department of Haematology, Royal Free and University College Medical School, University College London, U.K.
,
C. A. Lee
1   From the Katharine Dormandy Haemophilia Centre and Haemostasis Unit, Department of Haematology, Royal Free and University College Medical School, University College London, U.K.
› Author Affiliations
Further Information

Publication History

Received 31 December 1998

Accepted 08 February 1999

Publication Date:
09 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Baglin T, Beacham E.. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor? Thromb Haemost. 1998; 80:: 1036-7.
    PubMedGoogle Scholar
  • 2 Yee TT, Lee CA, Riddel A, Pasi KJ. From Tolerance to Intolerance of factor VIII: A Clinical Case Presentation. C.M.E.. Bulletin 1997; 1: 16-7.
    PubMedGoogle Scholar
  • 3 Antonarakis SE, Kazazian HH, Gitschier J, Hutter P, de Moerloose P, Morris MA. Molecular etiology of factor VIII deficiency in haemophilia A. Advances in experimental medicine and biology.. Ed by Aledort L. M., Hoyer L. W., Lusher J. M., Reisner H. M., and C. G.. White II. 1996; 386: 19-34.
    PubMedGoogle Scholar
  • 4 Lee CA. Investigation of chronic hepatitis C infection in individuals with haemophilia.. Br J Haematol 1997; 96: 425
    CrossrefPubMedGoogle Scholar